# Synergistic Combinations of Native Australian Plants For Skin Inflammation and Wound Healing

**Authors:** Rotina Kapini, Dennis Chang, Gerald Münch, Lisa Carroll, Xian Zhou

PMC · DOI: 10.3390/biomedicines13071754 · 2025-07-17

## TL;DR

This study explores how combining extracts from three Australian native plants can help reduce skin inflammation and promote wound healing through antioxidant and anti-inflammatory effects.

## Contribution

The study identifies a synergistic combination of three native Australian plant extracts for skin inflammation and wound healing.

## Key findings

- Bitter orange, mountain pepper berry, and native river mint showed strong antioxidant and anti-inflammatory properties.
- The three-way combination of these extracts synergistically reduced NO and IL-6 levels and enhanced Nrf2 activation.
- The combination promoted wound healing in LPS-inflamed human dermal fibroblasts.

## Abstract

Background: Inflammation and oxidative stress are key mechanisms in underlying skin conditions like psoriasis and eczema. While many plants, including Australian native plants, are proposed to target these pathways due to their phytochemical content, studies on whole extracts and their synergistic effects remain limited. Objectives: This study aimed to investigate individual and combined effects of whole plant extracts on skin protection and healing, focusing on their anti-inflammatory and antioxidant properties. Methods: The antioxidant potential of the individual and combined plant extracts were investigated on 2,2-diphenyl-1-picrylhydrazyl (DPPH) and reactive oxygen species (ROS) assay followed by luciferase assay in MCF-7 AREc32 cells for nuclear factor erythroid 2-related factor 2 (Nrf2) activation. The anti-inflammatory activities were investigated on lipopolysaccharide (LPS)-induced RAW 264.7 murine macrophages for the inhibition of nitric oxide (NO), tumour necrosis factor (TNF)-α, and interleukin (IL)-6. Synergistic interaction was determined by the combination index model (CI < 1). Combination(s) showing synergistic and optimal activity were further investigated on LPS-induced human dermal fibroblasts (HDF) cells for IL-6 inhibition and wound healing activity. Results: Three of the tested Australian native plant extracts demonstrated prominent antioxidant and anti-inflammatory activities including bitter orange, mountain pepper berry and native river mint. In particular, their three-way combination (1:1:1, w/w) showed prominent synergistic (CI < 1) in reducing NO and IL-6, along with enhanced Nrf2 activation. In LPS-inflamed HDF cells, the combination maintained synergistic inhibition of IL-6 levels and promoted wound healing response. Conclusions: These findings highlight the therapeutic potential of Australian native plant as a whole extract for skin protection and repair attributed to antioxidant and anti-inflammatory activities. The observed synergistic anti-inflammatory and antioxidant effects support their use in the development of new cosmetic formulations for skin.

## Linked entities

- **Proteins:** GABPA (GA binding protein transcription factor subunit alpha)
- **Chemicals:** NO (PubChem CID 24822), IL-6 (PubChem CID 165368475)
- **Diseases:** psoriasis (MONDO:0005083), eczema (MONDO:0004980)

## Full-text entities

- **Genes:** NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** eczema (MESH:D004485), psoriasis (MESH:D011565), Inflammation (MESH:D007249)
- **Chemicals:** 2,2-diphenyl-1-picrylhydrazyl (MESH:C004931), LPS (MESH:D008070), ROS (MESH:D017382), NO (MESH:D009569)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HDF — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_U509), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), AREc32 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_1D32), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12293028/full.md

---
Source: https://tomesphere.com/paper/PMC12293028